GPR52 agonists represent a novel approach to treat psychotic disorders and improve cognitive function

A.J. Grottick, Niklas Schülert,Holger Rosenbrock, M. Von Heimendahl,Roberto Arban,Scott Hobson

EUROPEAN NEUROPSYCHOPHARMACOLOGY(2017)

引用 0|浏览9
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要